Health Subcommittee Markup

The House Committee on Energy and Commerce's Health Subcommittee held a markup session on June 26, 2026, focusing on a series of bipartisan health care transparency and public health bills. Key procurement-related discussions included advancing legislation to codify and enhance price transparency requirements for hospitals and insurers, improve reporting on prior authorization denial rates, and increase data transparency for Medicare Advantage supplemental benefits. The subcommittee also considered bills addressing the opioid epidemic, such as scheduling the veterinary drug xylazine as a controlled substance to curb illicit use, and improving emergency department fentanyl testing. Several amendments were proposed and withdrawn, with commitments to continue refining the bills before full committee markup. The session included votes forwarding multiple bills to the full committee, including the Lower Cost More Transparency Act, the Prior Authorization Accountability Act, and legislation to improve community health center services and Medicare Advantage oversight. The meeting emphasized enhancing consumer access to clear pricing and ownership information to empower informed health care decisions and reduce costs.